Ph.D. Paul A. Wagner - 12 May 2022 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
CEO, President, Secretary and Chair of the Board, Director
Signature
/s/ Paul A. Wagner, Ph.D
Issuer symbol
FBRX
Transactions as of
12 May 2022
Net transactions value
$0
Form type
4
Filing time
16 May 2022, 17:05:47 UTC
Previous filing
18 Jan 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FBRX Stock Option (right to buy) Disposed to Issuer $0 -40,000 -23% $0.000000 135,000 12 May 2022 Common Stock 40,000 $39.66 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 40,000 of the shares subject to this option were canceled by mutual agreement of the Reporting Person and the Issuer.
F2 Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 9, 2021.

Remarks:

CEO, President, Secretary and Chair of the Board